Health Care Data and Analytics M&A update, 14–28 September 2026
This bi-weekly update tracks share-price moves, company news and M&A activity across nine covered Health Care Data and Analytics names for September 14–28, 2026. It is built for operators, acquirers and advisors monitoring sector valuation and deal reference points.
For information only. Not an appraisal or a fairness opinion.
The deeper read: Health Care Data and Analytics Sector Outlook — September 2026
Key figures
- Sector median share-price move
- -6.0%
- 9 covered names, Sept 14–28
- S&P 500 return
- +0.8%
- same window
- Precedent transaction multiple
- 14.7x
- median EV/LTM EBITDA, 40 deals
- Widest mover
- +15.2%
- Fortrea Holdings Inc. (FTRE)
Read the report
1 / 7 · HEALTH CARE › HEALTH CARE EQUIPMENT AND SERVICES › HEALTH CARE DATA AND ANALYTICS
Executive summary
Share prices fell broadly across the covered group, with 7 of 9 names down and a -6.0% median move against a +0.8% S&P 500 return, while company news centered on contracted work rather than capital events. Two Core-tier names moved in opposite directions—Fortrea Holdings Inc. (FTRE) up 15.2% and Guardian Pharmacy Services, Inc. (GRDN) down 12.4%—showing tier membership did not predict direction this period. No new transactions were added, so the trailing 40-deal record and its 14.7x median EV/EBITDA remain the reference for private pricing.
Key findings
- 7 of 9 covered names fell; median move -6.0% vs S&P 500 +0.8%
- Two Core-tier names diverged: FTRE +15.2%, GRDN -12.4%, same tier
- Company news was about contracted work and awards, not capital events
- No new deals added; 40-deal record at 14.7x median EV/EBITDA still anchors pricing
What each page shows
The analyst’s walkthrough of the deck, page by page.
- 01BI-WEEKLY INDUSTRY EVENTS & M&A UPDATE
HEALTH CARE › HEALTH CARE EQUIPMENT AND SERVICES › HEALTH CARE DATA AND ANALYTICS
Cover slide introducing the Health Care Data and Analytics bi-weekly industry events and M&A update for September 14–28, 2026.
This bi-weekly update covers what changed, who moved and most likely why, what transacted, and what it means for Health Care Data and Analytics from September 14 to 28, 2026. We built it so operators, acquirers and advisors can act on the two-week record without digging through source filings themselves.
Everything on this page
BI-WEEKLY INDUSTRY EVENTS & M&A UPDATE HEALTH CARE › HEALTH CARE EQUIPMENT AND SERVICES › HEALTH CARE DATA AND ANALYTICS Operators Keep Signing Work While the Market Marks the Group Down This update covers sector events, share-price moves and transaction activity for September 14–28, 2026. September 14–28, 2026 Prepared by NeuraCap AI · Confidential Market data through 2026-09-28 · events and transactions from the two-week period 2026-09-14 → 2026-09-28 Health Care Data and Analytics Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice Sources & methodology 1
- 02THE BI-WEEKLY BOTTOM LINE
A Broad Pullback in Share Prices, with Company News Pointing the Other Way
Summarizes the two-week period: a broad share-price pullback despite constructive company news.
Seven of nine covered names fell over the two weeks, with a -6.0% median move against a +0.8% S&P 500 return, so the drawdown sits with this group rather than the broad market. Two Core-tier names split hard — Fortrea Holdings Inc. (FTRE) up 15.2% and Guardian Pharmacy Services, Inc. (GRDN) down 12.4% — showing tier alone did not decide direction. The company record itself was about contracted work: a public-sector award and results-call date at ICF International, Inc. (ICFI), a language-access partnership at Evolent Health, Inc. (EVH), and a results-call date at Medpace Holdings, Inc. (MEDP). No transactions were added, so the trailing 40-deal record at a 14.7x median EV/EBITDA still sets the private pricing reference. Together this tells us the pullback was a pricing move, not a signal from the underlying business record.
Everything on this page
THE BI-WEEKLY BOTTOM LINE A Broad Pullback in Share Prices, with Company News Pointing the Other Way The two-week period in one page · 9 covered names, close-to-close · September 14–28, 2026 Source: NeuraCap analytics platform (universe, prices, filings, transaction records); publisher-sourced news where linked; market data through 2026-09-28. Driver attributions use calibrated language and are NeuraCap reads of the recorded evidence. Health Care Data and Analytics Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice Sources & methodology 2 1 Seven of Nine Covered Names Fell over the Two-Week Period 7 of 9 covered names fell; the median move was -6.0%. The S&P 500 returned +0.8% over the same window, so the drawdown was concentrated in this group rather than the broad market. 2 Direction Split Inside the Same Valuation Tier Fortrea Holdings Inc. (FTRE) rose +15.2% and Guardian Pharmacy Services, Inc. (GRDN) fell -12.4% over the two-week period. Both sit in the Core tier of NeuraCap's standing sector view, so tier membership did not predict direction here. 3 The Company Record Was About Contracted Work, Not Capital Events Four items reached the period: a public-sector award and a results-call date at ICF International, Inc. (ICFI), a language-access partnership at Evolent Health, Inc. (EVH), and a results-call date at Medpace Holdings, Inc. (MEDP). 4 Private Pricing Reference Stayed Where It Was No transactions were added this period, so the trailing record of 40 precedent transactions and its 14.7x median EV/EBITDA remains the reference point against a CY2027E sector median of 1.1x EV/Revenue. +15.2% Best mover — Fortrea Holdings Inc. (FTRE) worst: GRDN -12.4% · 2 up / 7 down of 9 covered -6.0% Sector median two-week return vs S&P 500 +0.8%
- 03PUBLIC MARKET MOVERS
Who Moved — and What the Record Says About Why
Shows which covered names moved most and links each move to the recorded filings or headlines behind it.
We attribute each name's move only to filings and headlines recorded in the window, and where nothing was recorded, the page says so plainly. The sector median moved -6.0% against a +0.8% S&P 500 return, and Fortrea Holdings Inc. (FTRE) at +15.2% and Guardian Pharmacy Services, Inc. (GRDN) at -12.4% were the widest swings, both without a clear driver in the record. Our materiality bar is set at ±12.5% on a sector-relative basis, so moves inside that band are read as noise rather than signal. That distinction matters because it tells a client which moves deserve a follow-up call and which do not.
Everything on this page
PUBLIC MARKET MOVERS Who Moved — and What the Record Says About Why Bi-Weekly moves, close-to-close · September 14–28, 2026 · sector median -6.0% · S&P 500 +0.8% · materiality bar ±12.5% (sector-relative) Source: NeuraCap analytics platform (universe, prices, filings, transaction records); publisher-sourced news where linked; market data through 2026-09-28. Attribution links each move only to filings and headlines recorded in the window; where no driver is recorded, the page says so. Calibrated language throughout — NeuraCap reads, not asserted causation. Health Care Data and Analytics Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice Sources & methodology 3 Bi-Weekly return per company · teal above zero, amber below · sector median -6.0% Guardian Pharmacy Services, Inc. (GRDN) -12.4% Shares moved -12.4%. Defense World reported on Sep 21: "Guardian Pharmacy Services, Inc". The move appears to reflect that development, though the record does not establish a single driver. A move this size shows which operating model the market is paying for; the driver pages carry the detail. COMPANY-SPECIFIC Fortrea Holdings Inc. (FTRE) +15.2% No notable in-window news was identified that clearly explains the move. The move (+15.2%) ran ahead of the sector median (-6.0%). A move this size shows which operating model the market is paying for; the driver pages carry the detail. UNEXPLAINED
- 04MAJOR NEWS & INDUSTRY CATALYSTS
Contracted Work and the Results Calendar Carried a Quiet Two-Week Period
Lists the two-week period's highest-impact company events and why each matters.
The record for this period centers on contracted work and the results calendar rather than capital events: a public-sector award and a results-call date at ICF International, Inc. (ICFI), a language-access partnership at Evolent Health, Inc. (EVH), and a results-call date at Medpace Holdings, Inc. (MEDP). Each item links back to its filing or article, and our reliability order favors SEC filings and press releases over general coverage. That means the underlying business activity was constructive even as share prices moved the other way, which is the disconnect we flagged on the bottom-line page.
Everything on this page
MAJOR NEWS & INDUSTRY CATALYSTS Contracted Work and the Results Calendar Carried a Quiet Two-Week Period The two-week period's highest-impact events · titles link to the underlying filing or article · September 14–28, 2026 Source: NeuraCap analytics platform (universe, prices, filings, transaction records); publisher-sourced news where linked; market data through 2026-09-28. "Why it matters" lines are NeuraCap reads; each event links to its source. Sources are admitted in a fixed reliability order (SEC filings, press releases, established outlets); video and social platforms are never used. Health Care Data and Analytics Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice Sources & methodology 4 Sep 28 · NEWS · PRNewsWire Los Angeles County awarded ICF two new multi-year energy efficiency work orders This is programme-linked, publicly funded work that adds to contracted backlog. NeuraCap reads awards of this type as the kind of long-dated, budget-protected revenue the bid side underwrites most comfortably. Contracted public-sector work keeps supporting backlog while share prices in the group move the other way. Sep 24 · NEWS · PRNewsWire ICF set the date for its third quarter results call A fixed calendar date puts the next test of contract conversion and award momentum in early November. NeuraCap reads it as a signal that management is running to a normal cadence after a period of price weakness. The next observable checkpoints for this group are scheduled, not scattered. Sep 21 · NEWS · GlobeNewsWire Evolent expanded an enterprise-wide telephonic interpretation partnership for health plan members Language access sits inside the member-servicing workflow that supports quality measurement and plan satisfaction. Workflow depth with payers is where Discount-tier names have the clearest path to recurring economics. Sep 22 · NEWS · Business Wire Medpace fixed a late-October date for its third quarter results call For a Premium-tier name, the next call is where net new business awards, cancellations and book-to-bill get tested. NeuraCap reads a routine calendar item as a sign of steady operating cadence. Sponsor-funded research demand is judged on awards and cancellations, and the next reading is close.
- 05M&A & STRATEGIC ACTIVITY
No New Transactions Landed, so the Existing Record Still Sets the Reference
States that no new transactions were recorded this period, leaving the existing 40-deal record as the reference.
No new transactions landed in this window, so we did not re-present old deals as news. The standing precedent set of 40 recorded deals at a 14.7x median EV/LTM EBITDA remains the reference point for private pricing, against a CY2027E sector median of 1.1x EV/Revenue. For acquirers and advisors, that means valuation conversations can still anchor on the existing multiple even without a fresh print this period.
Everything on this page
M&A & STRATEGIC ACTIVITY No New Transactions Landed, so the Existing Record Still Sets the Reference September 14–28, 2026 · precedent transactions: 40 recorded deals · median 14.7x EV/LTM EBITDA Source: NeuraCap analytics platform (universe, prices, filings, transaction records); publisher-sourced news where linked; market data through 2026-09-28. Deal multiples are LTM at announcement where disclosed; "why the deal happened" is a NeuraCap read of the recorded evidence. No old transactions are re-presented as news. Health Care Data and Analytics Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice Sources & methodology 5 No Material Transactions Announced No material sector transactions were announced during the period. The trailing record of 40 precedent transactions, at a 14.7x median EV/EBITDA, remains the observable pricing reference for the sector. A quiet two-week period is information: buyer appetite, financing conditions and seller expectations all read through a period with no new deals. The precedent transactions alongside still frame what buyers have paid. 40 Recorded precedent transactions the reference set buyers and sellers price against 14.7x Precedent median EV/LTM EBITDA LTM at announcement, where disclosed
- 06WHAT IT MEANS
What the Two-Week Period Changes for Operators, Buyers and Advisors
Translates the two-week period's evidence into implications for operators, acquirers and advisors.
For owners and operators, the operating evidence — contracted backlog, book-to-bill, net new awards and retention — carried this period, not price action. For acquirers, the reference set is unchanged: the trailing 40-transaction record at 14.7x median EV/EBITDA still anchors private pricing even as public values softened, with 7 of 9 covered names lower and a -6.0% median move. For advisors, the split between Fortrea Holdings Inc. (FTRE) and Guardian Pharmacy Services, Inc. (GRDN) inside the same Core tier argues for leading with contract form rather than the sector label. These are observations from the recorded evidence, not recommendations, so each audience can weigh them against its own position.
Everything on this page
WHAT IT MEANS What the Two-Week Period Changes for Operators, Buyers and Advisors The two-week period translated for the people who act on it · NeuraCap view · observations, not recommendations Source: NeuraCap analytics platform (universe, prices, filings, transaction records); publisher-sourced news where linked; market data through 2026-09-28. This page is analytical interpretation drawn from the two-week period's recorded evidence. It is not investment advice. Health Care Data and Analytics Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice Sources & methodology 6 Sector study 2026-09-28 EV / Revenue (CY2027E) median 1.1x 10 companies in the study 3 valuation tiers Standing thesis: Health Care Data and Analytics Splits Between Recurring Data Platforms and Services-Led Models FOR OWNERS & OPERATORS Operating Evidence, Not Price Action, Is What Carried This Period Companies in the space kept adding contracted work and deepening payer workflow. The measures that support that are contracted backlog and book-to-bill, net new business awards against cancellations, revenue retention and cross-sell attach FOR ACQUIRERS The Reference Set Is Unchanged, While Public Values Softened No transactions were added, so the trailing 40-transaction record and its 14.7x median EV/EBITDA still anchor private pricing. Public values moved down over the period, with 7 of 9 covered names lower and a -6.0% median move. FOR ADVISORS Lead with Contract Form, Because the Label Is Not Doing the Work The period extends NeuraCap's standing thesis that this sector splits between recurring data platforms and services-led models. Two Core-tier names produced moves in opposite directions, and the company record was about awards and payer workflow.
- 07SOURCES & METHODOLOGY
Sources, Methodology and Important Notice
Explains the sources and methodology behind every figure and statement in this update.
Every figure in this update links back to the record it was taken from, and driver attributions use calibrated language rather than asserted causation. We rely on a fixed reliability order — SEC filings, press releases, then established outlets — and never draw on video or social platforms. That discipline is what lets a client trust each number in this deck without re-verifying it independently.
Everything on this page
SOURCES & METHODOLOGY Sources, Methodology and Important Notice How this bi-weekly update is built and what each kind of statement rests on · September 14–28, 2026 · market data through 2026-09-28 Every figure in this update links to the record it was taken from; the publishers and filings drawn on for the period are listed above. Health Care Data and Analytics Bi-Weekly Update | September 14–28, 2026 | Confidential | Not investment advice 7 OBSERVED DATA Bi-Weekly stock moves are computed close-to-close over the stated window from the platform’s price series. Deal records, values and multiples come from the platform’s transaction record (SEC 8-K extractions) exactly as recorded; each figure links to its citation. Treasury rates come from the platform’s Treasury series and are shown only when the 10-year moved at least ten basis points over the window (it did not in this window, so no rate figures appear). UNIVERSE QUALITY The update universe is the platform’s approved company set for this sector, subject to a $100M market-cap floor so small, loosely related names cannot dominate the statistics. 2 names below the floor were excluded from movers and statistics for this window. EVENTS & NEWS Company events are in-window 8-K filings; news items are publisher-sourced headlines fetched for the window (and any externally supplied items, marked as such). Operational and strategic developments (deals, partnerships, launches, expansion, guidance, leadership, regulatory outcomes) are shown first; capital-return mechanics and conference appearances are limited to one each. Every event links to its source. The deck never asserts an event that has no linked record. SOURCE HIERARCHY News is admitted in a fixed order of reliability: SEC filings first, then company press releases and investor-relations communications, then transaction documents, then established outlets (Reuters, CNBC, The Wall Street Journal, Barron’s and peers). Video and social platforms — including YouTube — are never used as sources. DRIVER ATTRIBUTION A stock move is linked to an event only when the event falls inside the window, and only in calibrated language ("the move appears to reflect…", "shares moved following…"). Where no driver is recorded, the page says so and compares the move to the sector median instead. ANALYTICAL INTERPRETATION "Why it matters", "why the deal happened" and the what-it-means page are NeuraCap analytical views drawn from the recorded evidence, and are labeled as such. INHERITED CONTEXT The standing sector view (thesis, valuation lens, sector median and tiering) is inherited from the NeuraCap sector study run_20260929T171516Z_547_prod (market data as of 2026-09-28) — distilled, never re-derived. That report’s own sources page governs its content; this update reads the period against it. IMPORTANT NOTICE This report is informational only. It is not investment advice, not a recommendation to buy or sell any security, and not an offer of any kind. Readers should perform their own diligence before acting on anything described here. Linked sources this two-week period: prnewswire.com · globenewswire.com · businesswire.com
Sources and methodology
This update covers Health Care Data and Analytics over the 14-day window September 14–28, 2026; market data runs through September 28, 2026. The universe is the 9 listed companies whose core business is Health Care Data and Analytics under NeuraCap's industry classification, subject to a $100M market-capitalisation floor so that very small, loosely related names cannot dominate the movers and statistics. Companies covered: Evolent Health, Inc. (EVH), Fortrea Holdings Inc. (FTRE), Guardian Pharmacy Services, Inc. (GRDN), ICF International, Inc. (ICFI), Medpace Holdings, Inc. (MEDP), NeuroPace, Inc. (NPCE), NRC Health (NRC), Progyny, Inc. (PGNY), Privia Health Group, Inc. (PRVA). 2 names below the floor were excluded from the statistics: DH, DLHC.
Window and company universe
This update covers Health Care Data and Analytics over the 14-day window September 14–28, 2026; market data runs through September 28, 2026. The universe is the 9 listed companies whose core business is Health Care Data and Analytics under NeuraCap's industry classification, subject to a $100M market-capitalisation floor so that very small, loosely related names cannot dominate the movers and statistics. Companies covered: Evolent Health, Inc. (EVH), Fortrea Holdings Inc. (FTRE), Guardian Pharmacy Services, Inc. (GRDN), ICF International, Inc. (ICFI), Medpace Holdings, Inc. (MEDP), NeuroPace, Inc. (NPCE), NRC Health (NRC), Progyny, Inc. (PGNY), Privia Health Group, Inc. (PRVA). 2 names below the floor were excluded from the statistics: DH, DLHC.
How the moves and statistics are computed
Each company's period move is the change in closing price from the last close before the window to the last close inside it (close-to-close). The sector median is the median of those moves across the covered names; the index return is computed the same way for the S&P 500 over the same dates. The largest single-day move inside the window is shown for each mover. Movers are the largest gainers and losers by period move; the attribution cards prefer movers whose in-window record explains the move. Movers carry the valuation tier assigned in the standing sector study (the latest NeuraCap sector outlook) where that study rated them.
Events, news and how a move is attributed
Company events are the 8-K filings made inside the window; news items are publisher-sourced headlines for the window, admitted in a fixed order of reliability: SEC filings first, then company press releases and investor-relations communications, then established outlets (Reuters, CNBC, The Wall Street Journal, Barron's and peers). Video and social platforms are never used. A move is linked to an event only when the event falls inside the window and only in calibrated language; where nothing in the record explains a move, the update says so rather than speculating. Every event links to its source.
Transactions in the window and the trailing record
Transactions are taken from SEC filings by announcement date; 0 were announced inside the window. The trailing record of 40 recorded transactions provides the reference multiples (EV over last-twelve-month revenue or EBITDA at announcement, as disclosed). A value whose own citation describes something other than the price paid is not shown as the deal value; transactions where the acquirer and the target are the same entity are treated as reorganisations and excluded.
Sources
Prices and index levels are market data through September 28, 2026; filings are the companies' SEC filings on EDGAR; press releases are the companies' own; other news items are from the established outlets named on each card; Treasury yields are published by the U.S. Department of the Treasury. Every figure and every event in the update links to its record.
Interpretation and important notice
'Why it matters', 'why the deal happened' and the what-it-means page are NeuraCap analytical views drawn from the recorded evidence, labelled as such. The update is informational: it is not investment advice, not a recommendation to buy or sell any security and not an offer of any kind.
Sources linked in the report
- -12.4% (defenseworld.net)
- Los Angeles County awarded ICF two new multi-year energy efficiency work (prnewswire.com)
- ICF set the date for its third quarter results call (prnewswire.com)
- Evolent expanded an enterprise-wide telephonic interpretation partnership (globenewswire.com)
- Medpace fixed a late-October date for its third quarter results call (businesswire.com)
This report is published for information only. It is not a recommendation to buy or sell any security, an offer or solicitation, an appraisal or a fairness opinion, and no fiduciary relationship is created by reading it. Multiples that fail NeuraCap’s plausibility gates are excluded and never plotted. See the full methodology and the disclaimer.
More coverage in Health Care
- Sector Outlook · 29 September 2026Health Care Data and Analytics Sector Outlook — September 2026
- M&A Update · 29 September 2026Health Care Distributors M&A update, 14–28 September 2026
- Sector Outlook · 29 September 2026Health Care Distributors Sector Outlook — September 2026
- M&A Update · 29 September 2026Health Care Equipment and Supplies M&A update, 14–28 September 2026
Want this analysis for a company in Health Care Data and Analytics?
Company valuation reports run the same method against a single business — public or private.
